Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs

E-ISSN： 1873-5576|12|8|962-986

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.8, 2012-10, pp. : 962-986

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of membrane transporters in the safety profile of drugs

By Lee Edmund Jon Deoon Lean Choo Bee Limenta Lie Michael George

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 11, 2009-11 ,pp. : 1369-1383

Informa Healthcare

Access to resources Recommend Favorite

Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs

By Gibson D. Binyamin I. Haj M. Ringel I. Ramu A. Katzhendler J.

European Journal of Medicinal Chemistry, Vol. 32, Iss. 10, 1997-10 ,pp. : 823-831

Elsevier

Access to resources Recommend Favorite

Trans-Platinum Complexes as Anticancer Drugs: Recent Developments and Future Prospects

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1611-1618

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 21, 2011-11 ,pp. : 2623-2631

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Drug Delivery System for Platinum-based Anticancer Drugs

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 11, 2016-05 ,pp. : 872-891

Bentham Science Publishers

Access to resources Recommend Favorite